Industry Trend Analysis - Respiratory Disorders To Continue On An Upward Trajectory - DEC 2017
BMI View : Cameroon contends with a variety of infectious diseases, yet the gradually evolving epidemiological profile will provide greater revenue earning opportunities for pharmaceutical companies producing chronic disease treatments. However, we do not expect any significant investment from multinational drugmakers over the near-to-medium-term, with underlying weaknesses in the pharmaceutical sector weighing on patented drugmaker ' s potential. Indeed, generic products will maintain a dominant share of the market in both value and volume terms.
Cameroon's disease profile will continue to evolve in line with economic and demographic trends. While the population will continue to suffer from a significant underlying burden of infectious diseases, the burden of non-communicable diseases will continue to increase at a faster rate due to the growing middle class and resulting lifestyle changes.
COPD To Drive Respiratory Disorders
A Significant Burden Cameroon: Respiratory Diseases, Total (DALYs) f = forecast. DALYs = disability-adjusted life years. Source: BMI's Disease Database
This article is part of our Middle East & Africa coverage. To access this article subscribe now or sign up for free trial